Your browser doesn't support javascript.
loading
The research of rBCG inhibiting function on EB virus positive tumors / 中华实验和临床病毒学杂志
Chinese Journal of Experimental and Clinical Virology ; (6): 89-91, 2017.
Artigo em Chinês | WPRIM | ID: wpr-808142
ABSTRACT
Objective@#The inhibition function on EB virus positive tumors with rBCG (recombinant BCG) was researched.@*Methods@#After cancer models of EB virus positive tumor cells(GT39)were established in C57BL/6 mice, the mice survival conditions, tumor weight and tumor formation time were analyzed, flow cytometry was used to research the proliferation of CD4+ T. Inhibition of rBCG to cancer was researched, HE staining of the mice tumor tissue was used to detect and analyze lymphocyte infiltration. Single factor analysis method of variance (One-way ANOVA) was processed for rBCG′s inhibition evaluation by SPSS 11.0 statistical software.@*Results@#Compared with the control group, rBCG group significantly slowed tumor growth, tumor formation time was delayed, rBCG significantly prolonged survival time of the mice.@*Conclusions@#rBCG had inhibition to EB virus positive tumors in mice.

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Tipo de estudo: Estudo prognóstico Idioma: Chinês Revista: Chinese Journal of Experimental and Clinical Virology Ano de publicação: 2017 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Tipo de estudo: Estudo prognóstico Idioma: Chinês Revista: Chinese Journal of Experimental and Clinical Virology Ano de publicação: 2017 Tipo de documento: Artigo